论文部分内容阅读
本月全球药品研发进展取得成效的药物共有43个,较上月大幅减少28个。进入注册阶段的有25个,较上月减少10个。其中,9个为全球首次注册的药品,在新市场补充注册的为16个。进入注册前阶段的有9个,较上月增加3个。进入Ⅲ期临床研究阶段的有9个,较上月减少21个。
There were 43 drugs that made progress in global drug research and development this month, a sharp decrease of 28 from the previous month. There were 25 registrations, a decrease of 10 from the previous month. Among them, 9 are the first drugs registered in the world and 16 are newly registered in the new market. There were nine before entering the registration phase, an increase of three from the previous month. Nine of them entered phase III clinical research, down 21 from the previous month.